Literature DB >> 3011049

Genetic predisposition to human lung cancer.

J Heighway, N Thatcher, T Cerny, P S Hasleton.   

Abstract

The influence of polymorphic variants of the human c-Ha-ras gene on predisposition to lung cancer has been investigated. The human c-Ha-ras gene has been shown to reside on a polymorphic BamH1 restriction fragment. This restriction fragment length polymorphism (RFLP) results from variation in the size of a region of repetitive DNA 3' to the gene. An attempt has been made to characterise and compare the c-Ha-ras RFLP's in a normal population and in a group of cancer patients. DNA was extracted from the white blood cells of 101 normal donors and four common Ha-ras alleles identified, with occasional rare alleles of various sizes. The allele frequencies were examined in 132 lung cancer patients, comprising 66 individuals with small cell carcinoma of the lung (SCCL) and 66 with non-small cell carcinoma of the lung (non-SCCL). An abnormal allele distribution was found in individuals with non-SCCL compared to both control and SCCL values suggesting a degree of genetic pre-position to non-SCCL. In addition, analysis of the Ha-ras RFLP's in solid samples inferred a deletion of material from the short arm of chromosome 11 in two of 16 informative samples.

Entities:  

Mesh:

Year:  1986        PMID: 3011049      PMCID: PMC2001439          DOI: 10.1038/bjc.1986.72

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

2.  Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors:  L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

3.  A simple method for the preparation of large quantities of pure plasmid DNA.

Authors:  G O Humphreys; G A Willshaw; E S Anderson
Journal:  Biochim Biophys Acta       Date:  1975-04-02

4.  Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue.

Authors:  D J Capon; E Y Chen; A D Levinson; P H Seeburg; D V Goeddel
Journal:  Nature       Date:  1983-03-03       Impact factor: 49.962

5.  Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster.

Authors:  S H Orkin; H H Kazazian; S E Antonarakis; S C Goff; C D Boehm; J P Sexton; P G Waber; P J Giardina
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

6.  The construction and partial characterization of plasmids containing complementary DNA sequences to human calcitonin precursor polyprotein.

Authors:  J Allison; L Hall; I MacIntyre; R K Craig
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

7.  Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene.

Authors:  Y Yuasa; S K Srivastava; C Y Dunn; J S Rhim; E P Reddy; S A Aaronson
Journal:  Nature       Date:  1983-06-30       Impact factor: 49.962

8.  Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells.

Authors:  M Goldfarb; K Shimizu; M Perucho; M Wigler
Journal:  Nature       Date:  1982-04-01       Impact factor: 49.962

9.  A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene.

Authors:  E P Reddy; R K Reynolds; E Santos; M Barbacid
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

10.  c-Ki-ras amplification in human lung cancer.

Authors:  J Heighway; P S Hasleton
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

View more
  34 in total

Review 1.  Demystified ... oncogenes.

Authors:  Y L Wallis; F Macdonald
Journal:  Mol Pathol       Date:  1999-04

2.  Formation of benzo[a]pyrene-DNA adducts in blood monocytes from lung cancer patients with a familial history of lung cancer.

Authors:  D Nowak; A Meyer; U Schmidt-Preuss; U Gatzemeier; H Magnussen; H W Rüdiger
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  Allele-specific deletion in exon I of the HRAS1 gene.

Authors:  A Kasperczyk; B A Mermer; D R Parkinson; J A Lonergan; T G Krontiris
Journal:  Am J Hum Genet       Date:  1989-11       Impact factor: 11.025

4.  TaqI polymorphism within the c-Ha-ras-1 VTR is associated with melanoma.

Authors:  N K Hayward; D J Nancarrow; P G Parsons; C Kidson; K A Ellem
Journal:  Hum Genet       Date:  1989-11       Impact factor: 4.132

5.  DNA tertiary structures formed in vitro by misaligned hybridization of multiple tandem repeat sequences.

Authors:  L W Coggins; M O'Prey
Journal:  Nucleic Acids Res       Date:  1989-09-25       Impact factor: 16.971

6.  Statistical methodology in the analysis of relationships between DNA polymorphisms and disease: putative association of Ha-ras-I hypervariable alleles and cancer.

Authors:  T E Peto; S L Thein; J S Wainscoat
Journal:  Am J Hum Genet       Date:  1988-04       Impact factor: 11.025

7.  Increased frequency of specific alleles of the c-Ha-ras gene in Japanese cancer patients.

Authors:  K Honda; K Ishizaki; M Ikenaga; J Toguchida; T Inamoto; K Tanaka; K Ozawa
Journal:  Hum Genet       Date:  1988-08       Impact factor: 4.132

8.  Distribution of Ha-ras alleles in patients with colorectal cancer and Crohn's disease.

Authors:  R Klingel; P Mittelstaedt; W G Dippold; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

9.  Loss of allelic heterozygosity at the harvey ras locus in human oral carcinomas.

Authors:  D Saranath; L T Bhoite; A R Mehta; V Sanghavi; M G Deo
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

10.  Mutant genes of cytochrome P-450IID6, glutathione S-transferase class Mu, and arylamine N-acetyltransferase in lung cancer patients.

Authors:  I Roots; J Brockmöller; N Drakoulis; R Loddenkemper
Journal:  Clin Investig       Date:  1992 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.